INS and Hypoglycemia: Supporting this interpretation are results from another small trial of praliciguat in individuals with diabetes and hypertension, in which hypoglycaemia was reported in only one person on concomitant insulin, and other trials conducted in healthy volunteers where hypoglycaemia was not observed [10].